BioAtla, Inc. (BCAB) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bioatla, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.554 Please stand by. Your program is about to begin. 00:00:11.564 -- 00:00:17.090 Good day, everyone, and welcome to the BioAtlas Second Quarter 2025 Earnings 00:00:17.090 -- 00:00:21.675 Call. At this time, all participants are in a listen-only mode. 00:00:21.675 -- 00:00:26.204 Later, you'll have the opportunity to ask questions during the question and answer session. 00:00:26.204 -- 00:00:31.110 You may register to ask a question at any time by pressing the star and one on your telephone 00:00:31.110 -- 00:00:35.896 keypad. We will be standing by if you should need any assistance, and it is my pleasure 00:00:35.896 -- 00:00:40.442 to turn today's conference over to Christy Grabowski with Life Science Advisors. 00:00:40.442 -- 00:00:42.524 Please go ahead. 00:00:42.524 -- 00:00:45.288 With me today on the phone from BioAlla are Dr. 00:00:45.288 -- 00:00:50.654 Jay Short, Chairman, CEO, and Co-Founder, and Richard Waldron, Chief Financial 00:00:50.654 -- 00:00:55.783 Officer. Following today's call, Dr. Eric Sievers, Chief Medical Officer, 00:00:55.783 -- 00:01:01.709 and Sherry Lydic, Chief Commercial Officer, will join Jay and Rick in a short Q&A. 00:01:01.709 -- 00:01:06.314 Earlier this afternoon, BioAtla released financial results and a business update for 00:01:06.314 -- 00:01:11.400 the second quarter ended June 30, 2025. A copy of the press release and 00:01:11.400 -- 00:01:15.144 corporate presentation are available on the company's website. 00:01:15.144 -- 00:01:19.709 Before we begin, I'd like to remind everyone that statements made during this conference 00:01:19.709 -- 00:01:24.960 call will include forward-looking statements, including but not limited to statements 00:01:24.960 -- 00:01:29.864 regarding BioAtlas business...